CRC Metastatic - capecitabine 1000 | 2.0.0 | 13/08/2023 |
CRC Metastatic - capecitabine 1250 | 2.0.0 | 13/08/2023 |
CRC Metastatic - capecitabine and beVACizumab | 2.0.0 | 13/08/2023 |
CRC Metastatic - capecitabine and mitomycin | 2.0.0 | 13/08/2023 |
CRC Metastatic - CAPOX [capecitabine and oxaliplatin] | 2.0.0 | 18/11/2024 |
CRC Metastatic - CAPOX [capecitabine and oxaliplatin] and beVACizumab | 2.0.0 | 18/11/2024 |
CRC Metastatic - CETUximab [Q1W] | 3.0.0 | 16/06/2023 |
CRC Metastatic - CETUximab [Q2W] and daBRAFEnib | 1.0.0 | 28/02/2024 |
CRC Metastatic - CETUximab [Q2W] and encorafenib | 1.0.0 | 28/02/2024 |
CRC Metastatic - CETUximab and irinotecan [Q2W] | 3.0.0 | 28/02/2024 |
CRC Metastatic - CETUximab Q2W | 1.0.0 | 03/03/2024 |
CRC Metastatic - FLOX [oxaliplatin, foliNIc acid and fluorouracil] | 2.0.0 | 18/11/2024 |
CRC Metastatic - irinotecan [Q3W] dose reduced | 1.0.0 | 03/03/2024 |
CRC Metastatic - irinotecan Q3W | 2.0.0 | 13/08/2023 |
CRC Metastatic - IrOX [oxaliplatin and irinotecan] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mCAPIRI [irinotecan and capecitabine] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mDe Gramont [foliNIc acid and fluorouracil] [high dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mDe Gramont [foliNIc acid and fluorouracil] [low dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid fluorouracil] and CETUximab [Q2W] [low dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] and beVACizumab [high dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] and beVACizumab [low dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid fluorouracil] and CETUximab [Q2W] [high dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and CETUximab [Q2W] [low dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and beVACizumab [high dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and beVACizumab [low dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and CETUximab [Q2W] [high dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] with beVACizumab [high dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] with beVACizumab [low dose foliNIc acid] | 3.0.0 | 18/11/2024 |
CRC Metastatic - mQUASAR [foliNIc acid and fluorouracil] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mRoswell Park [foliNIc acid and fluorouracil] [high dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - mRoswell Park [foliNIc acid and fluorouracil] [low dose foliNIc acid] | 2.0.0 | 18/11/2024 |
CRC Metastatic - pembrolizumab Q3W [flat dosing] | 1.0.0 | 29/02/2024 |
CRC Metastatic - pembrolizumab Q6W [flat dosing] | 1.0.0 | 29/02/2024 |
CRC Metastatic - raltitrexed | 2.0.0 | 13/08/2023 |
CRC Metastatic - raltitrexed and oxaliplatin | 2.0.0 | 13/08/2023 |
CRC Metastatic - regorafenib | 4.0.0 | 13/08/2023 |
CRC Metastatic - trifluridine/tipiracil | 1.0.0 | 29/02/2024 |
CRC Metastatic - trifluridine/tipiracil and beVACizumab | 1.0.0 | 29/02/2024 |
CRC REC Metastatic - capecitabine chemoradiation [5 day dosing] | 3.0.0 | 13/08/2023 |
CRC REC Metastatic - capecitabine chemoradiation [continuous dosing] | 3.0.0 | 13/08/2023 |
CRC REC Metastatic - fluorouracil chemoradiation | 3.0.0 | 13/08/2023 |